Wipfli Financial Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Wipfli Financial Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$4K	Buy	+204	New	+$3.2K	﹤0.01%	2178

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Wipfli Financial Advisors's DCPH Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2022: 204 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #2178 among its holdings.

150 funds tracked by Wall St. Rank hold DCPH as of Q3 2022.

Wipfli Financial Advisors held 204 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $4K as of Q3 2022.
Deciphera Pharmaceuticals, Inc. Common Stock was a new Wipfli Financial Advisors position in Q3 2022.
Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2178 holding.
150 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.